Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 5, 2014, Pages 870-877

  Gopal, Purva ^a   Yopp, Adam C ^a,b   Waljee, Akbar K ^d,e   Chiang, Jason ^a   Nehra, Mahendra ^a   Kandunoori, Pragathi ^a   Singal, Amit G ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AIDS; Biomarkers; Liver Disease; Screening

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; BIOLOGICAL MARKER;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; COMPLICATION; EVALUATION STUDY; LIVER NEOPLASMS; MIDDLE AGED; RETROSPECTIVE STUDY; TEXAS;

ALPHA-FETOPROTEINS; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TEXAS;

EID: 84899117264     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.09.053     Document Type: Article

References (27)

1. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
2. El-Serag H.B., Lau M., Eschbach K., et al. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 2007, 167:1983-1989.
3. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010, 53:1-35.
4. Finberg H.J. Whither (wither?) the ultrasound specialist?. JUltrasound Med 2004, 23:1543-1547.
5. Singal A., Volk M.L., Waljee A., et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009, 30:37-47.
6. Singal A.G., Conjeevaram H.S., Volk M.L., et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev 2012, 21:793-799.
7. Singal A.G., Nehra M., Adams-Huet B., et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?. Am J Gastroenterol 2013, 108:425-432.
8. Gupta S., Bent S., Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003, 139:46-50.
9. Takikawa Y., Suzuki K. Is AFP a new reliable marker of liver regeneration in acute hepatic failure?. JGastroenterol 2002, 37:681-682.
10. Di Bisceglie A.M., Sterling R.K., Chung R.T., et al. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. JHepatol 2005, 43:434-441.
11. Nguyen M.H., Garcia R.T., Simpson P.W., et al. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002, 36:410-417.
12. Volk M.L., Hernandez J.C., Su G.L., et al. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark 2007, 3:79-87.
13. Cedrone A., Covino M., Caturelli E., et al. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology 2000, 47:1654-1658.
14. Trevisani F., D'Intino P.E., Morselli-Labate A.M., et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. JHepatol 2001, 34:570-575.
15. Yang J.D., Kim W.R., Coelho R., et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011, 9:64-70.
16. Singal A.G., Yopp A.C., Gupta S., et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) 2012, 5:1124-1130.
17. Nehra M.S., Ma Y., Clark C., et al. Use of administrative claims data for identifying patients with cirrhosis. JClin Gastroenterol 2013, 47:e50-e54.
18. Mossman D., Somoza E. ROC curves, test accuracy, and the description of diagnostic tests. JNeuropsychiatry Clin Neurosci 1991, 3:330-333.
19. Bellentani S., Scaglioni F., Marino M., et al. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010, 28:155-161.
20. Starley B.Q., Calcagno C.J., Harrison S.A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010, 51:1820-1832.
21. Sterling R.K., Wright E.C., Morgan T.R., et al. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. Am J Gastroenterol 2012, 107:64-74.
22. Singal A.G., Thomassen L.V., Gretch D.R., et al. Use of the AST to platelet ratio index in HCV/HIV co-infected patients. Aliment Pharmacol Ther 2011, 33:566-577.
23. Brau N., Fox R.K., Xiao P., et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.Canadian multicenter study. JHepatol 2007, 47:527-537.
24. Yopp A.C., Subramanian M., Jain M.K., et al. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. Clin Gastroenterol Hepatol 2012, 10:1284-1290.
25. Di Bisceglie A.M., Lyra A.C., Schwartz M., et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003, 98:2060-2063.
26. Lee E., Edward S., Singal A.G., et al. Improving screening for hepatocellular carcinoma by incorporating data on levels of alpha-fetoprotein, over time. Clin Gastroenterol Hepatol 2013, 11:437-440.
27. Singal A.G., Mukherjee A., Elmunzer B.J., et al. Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol 2013, 108:1723-1730.